These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35747116)

  • 41. Homeopathic remedy for arsenic toxicity?: Evidence-based findings from a randomized placebo-controlled double blind human trial.
    Belon P; Banerjee A; Karmakar SR; Biswas SJ; Choudhury SC; Banerjee P; Das JK; Pathak S; Guha B; Paul S; Bhattacharjee N; Khuda-Bukhsh AR
    Sci Total Environ; 2007 Oct; 384(1-3):141-50. PubMed ID: 17628642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.
    Harrison SA; Ruane PJ; Freilich B; Neff G; Patil R; Behling C; Hu C; Shringarpure R; de Temple B; Fong E; Tillman EJ; Rolph T; Cheng A; Yale K
    JHEP Rep; 2023 Jan; 5(1):100563. PubMed ID: 36644237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.
    Sunil Kumar N; Remalayam B; Thomas V; Ramachandran TM; Sunil Kumar K
    J Clin Exp Hepatol; 2021; 11(2):163-170. PubMed ID: 33746440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arsenic toxicity from homeopathic treatment.
    Chakraborti D; Mukherjee SC; Saha KC; Chowdhury UK; Rahman MM; Sengupta MK
    J Toxicol Clin Toxicol; 2003; 41(7):963-7. PubMed ID: 14705842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosis.
    Frenette C; Kayali Z; Mena E; Mantry PS; Lucas KJ; Neff G; Rodriguez M; Thuluvath PJ; Weinberg E; Bhandari BR; Robinson J; Wedick N; Chan JL; Hagerty DT; Kowdley KV;
    J Hepatol; 2021 Feb; 74(2):274-282. PubMed ID: 33038432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homoeopathic Medicine Arsenicum album 30 C for Covid-19 in 2020: A Retrospective Analysis from Mass-level Data.
    Chaudhary A; Nayak D; Pandey S; R R; Khurana A; Study Group C
    Altern Ther Health Med; 2022 Oct; 28(7):72-79. PubMed ID: 36074959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Homeopathic Treatment in Patients with COVID-19: Analysis of Clinical Evolution and Comparison between Cases in 2020 and 2021.
    Fujino FMSDC; Olandim AACC; Coggan JA; Carvalho Junior AD; Bufalo AQS; Takeyama EN; Sant'Ana SC; Barnabé VD; Benites NR
    Homeopathy; 2023 Feb; 112(1):3-11. PubMed ID: 36049774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
    Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
    J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.
    Tacke F; Weiskirchen R
    Ann Transl Med; 2021 Apr; 9(8):729. PubMed ID: 33987427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunological Responses of Arsenicum album 30CH to Combat COVID-19: Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial in the Pathanamthitta District of Kerala.
    Suhana PA; Kusum L; Shruti JV; Sreekanth GP; Bijukumar D; Shaji Kumar RT; Muraleedharan KC; Kaushik S
    JMIR Res Protoc; 2023 Oct; 12():e48479. PubMed ID: 37843912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
    Ferron PJ; Gicquel T; Mégarbane B; Clément B; Fromenty B
    Biochimie; 2020 Dec; 179():266-274. PubMed ID: 32891697
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury.
    Hillman L; Gottfried M; Whitsett M; Rakela J; Schilsky M; Lee WM; Ganger D
    Am J Gastroenterol; 2016 Jul; 111(7):958-65. PubMed ID: 27045922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.
    Pavlik L; Regev A; Ardayfio PA; Chalasani NP
    Drug Saf; 2019 Jun; 42(6):701-711. PubMed ID: 30762163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homeopathic pathogenetic trials produce specific symptoms different from placebo.
    Möllinger H; Schneider R; Walach H
    Forsch Komplementmed; 2009 Apr; 16(2):105-10. PubMed ID: 19420956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.
    Regev A; Palmer M; Avigan MI; Dimick-Santos L; Treem WR; Marcinak JF; Seekins D; Krishna G; Anania FA; Freston JW; Lewis JH; Sanyal AJ; Chalasani N
    Aliment Pharmacol Ther; 2019 Mar; 49(6):702-713. PubMed ID: 30761572
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis.
    Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jansen C; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Jarcuska P; Steib C; Reiberger T; Acevedo J; Gatti P; Shawcross DL; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Danielsen KV; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solé C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Kani HT; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia-Lopez E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Praktiknjo M; Curto A; Pitarch C; Putignano A; Moreno E; Bernal W; Aguilar F; Clària J; Ponzo P; Vitalis Z; Zaccherini G; Balogh B; Gerbes A; Vargas V; Alessandria C; Bernardi M; Ginès P; Moreau R; Angeli P; Jalan R; Arroyo V;
    J Hepatol; 2021 May; 74(5):1097-1108. PubMed ID: 33227350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study.
    Satapathy SK; Roth NC; Kvasnovsky C; Hirsch JS; Trindade AJ; Molmenti E; Barish M; Hirschwerk D; Da BL; Bernstein D;
    Hepatol Int; 2021 Jun; 15(3):766-779. PubMed ID: 33826042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcomes of COVID-19 in Patients with Cirrhosis or Liver Transplantation.
    Choudhary NS; Dhampalwar S; Saraf N; Soin AS
    J Clin Exp Hepatol; 2021; 11(6):713-719. PubMed ID: 33994708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event.
    Agrawal S; Rana BS; Mitra S; Duseja A; Das A; Dhiman RK; Chawla Y
    J Clin Exp Hepatol; 2018 Mar; 8(1):95-97. PubMed ID: 29743800
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative Effectiveness of Pre-Identified Homeopathic Medicines in Asymptomatic COVID-19 Individuals Receiving Standard Care-An Open-Label, Randomized, Controlled Exploratory Trial.
    Varanasi R; Tomar S; Gupta S; Jaiswal P; Srivastava A; Parmar V; Chauhan S; Kumar A; Mishra SK; Khurana A
    Homeopathy; 2022 Nov; 111(4):252-260. PubMed ID: 35917822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.